ArticleBMC cancer2022
MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer.
Zhenhao Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBMC cancer2022
Zhenhao Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.